Research map: Integrated Immune, Epithelial and Lipid Pathways in NSAID‐Exacerbated Respiratory Disease

Back to the article

Papers in this map

  1. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells · Luzheng Xue · 2014 · 473 citations · Cited by this paper
  2. Sexual Health in Atopic Dermatitis: Impact of Skin Clinical Control · 2025 · Related
  3. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects · Annette T. Hastie · 2013 · 260 citations · Cited by this paper
  4. Temporal Patterns of Allergen Sensitisation in the General Population: The LEAD Study · 2026 · Related
  5. Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease · Katherine N. Cahill · 2014 · 234 citations · Cited by this paper
  6. Staphylococcus aureus and Staphylococcus lugdunensis Act in Concert to Disrupt the Nasal Epithelial Barrier · 2026 · Related
  7. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: A double-blind study · Monika Świerczyńska-Krępa · 2014 · 153 citations · Cited by this paper
  8. IL‐25 Disrupts the Nasal Epithelial Barrier in an Adapter Act1‐Dependent Manner · 2026 · Related
  9. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology · Whitney W. Stevens · 2020 · 136 citations · Cited by this paper
  10. A Real‐World Cross‐Sectional Study on Suspected Mast Cell Activation Syndrome: Multiple Heterogeneous Symptoms Identified · 2026 · Related
  11. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease · Jacqueline J. Eastman · 2017 · 98 citations · Cited by this paper
  12. Patient‐Reported Outcome Measures as Predictive Tools for Disease Control in Chronic Rhinosinusitis With Nasal Polyps: A Prospective Study · 2025 · Related
  13. Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease · Whitney W. Stevens · 2020 · 94 citations · Cited by this paper
  14. Unique Sensitization Patterns to Allergen Components in a Crustacean‐Allergic Australian Cohort · 2026 · Related
  15. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial · Hossein Esmaeilzadeh · 2015 · 88 citations · Cited by this paper
  16. Paucigranulocytic Asthma in Aspirin‐Hypersensitive Patients: Pleiotropic Regulation of Type 2 Biomarkers · 2026 · Related
  17. Immune modules shared by innate lymphoid cells and T cells · Michelle L. Robinette · 2016 · 80 citations · Cited by this paper
  18. Between Guidelines and Daily Practice: The Persistent Use of Parenteral Depot Corticosteroids in Germany · 2026 · Related
  19. Inflammatory heterogeneity in aspirin-exacerbated respiratory disease · William C. Scott · 2020 · 70 citations · Cited by this paper
  20. Sputum Eosinophil and Macrophage Changes After Aspirin Challenge in Patients With Nonsteroidal Anti‐Inflammatory Drug–Exacerbated Respiratory Disease · 2025 · Related
  21. Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug–exacerbated respiratory disease · Pascal Haimerl · 2020 · 65 citations · Cited by this paper
  22. ALOX15+ M2 macrophages contribute to epithelial remodeling in eosinophilic chronic rhinosinusitis with nasal polyps · Chang Liu · 2024 · 65 citations · Cited by this paper
  23. Fuelling the mechanisms of asthma: Increased fatty acid oxidation in inflammatory immune cells may represent a novel therapeutic target · Amir A. Al-Khami · 2017 · 52 citations · Cited by this paper
  24. Plasma 15-Hydroxyeicosatetraenoic Acid Predicts Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease · Elina Jerschow · 2017 · 48 citations · Cited by this paper
  25. High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients · Andrea Matucci · 2022 · 46 citations · Cited by this paper
  26. Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab · Alessandra Vultaggio · 2023 · 44 citations · Cited by this paper
  27. Update on Inflammatory Biomarkers for Defining Asthma Phenotype · Soyoon Sim · 2024 · 44 citations · Cited by this paper
  28. Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis · Whitney W. Stevens · 2021 · 38 citations · Cited by this paper
  29. Eicosanoid dysregulation and type 2 inflammation in AERD · Joaquim Mullol · 2021 · 37 citations · Cited by this paper
  30. New insights into the endotypes of chronic rhinosinusitis in the biologic era · Ming Wang · 2025 · 35 citations · Cited by this paper
  31. Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease · Bogdan Jakieła · 2020 · 32 citations · Cited by this paper
  32. IL-4Rα signaling promotes barrier-altering oncostatin M and IL-6 production in aspirin-exacerbated respiratory disease · Chongjia C. Chen · 2024 · 29 citations · Cited by this paper
  33. Surfactant protein D alleviates eosinophil‐mediated airway inflammation and remodeling in patients with aspirin‐exacerbated respiratory disease · Youngwoo Choi · 2018 · 28 citations · Cited by this paper
  34. Prostaglandin E 2 decrease in induced sputum of hypersensitive asthmatics during oral challenge with aspirin · Lucyna Mastalerz · 2018 · 24 citations · Cited by this paper
  35. Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement · Antonino Romano · 2025 · 23 citations · Cited by this paper
  36. Mechanistic and clinical updates in AERD: 2021-2022 · Whitney W. Stevens · 2023 · 21 citations · Cited by this paper
  37. Aspirin hypersensitivity diagnostic index ( AHDI ): In vitro test for diagnosing of N‐ ERD based on urinary 15‐oxo‐ ETE and LTE 4 excretion · Lucyna Mastalerz · 2024 · 21 citations · Cited by this paper
  38. Sex, Ethnicity, Body Mass Index, and Environmental Exposures Associated With NSAID-Exacerbated Respiratory Disease Symptom Sequence · Kelley N. Dages · 2023 · 20 citations · Cited by this paper
  39. Advances in mast cell biology · Joshua A. Boyce · 2022 · 19 citations · Cited by this paper

Source: OpenAlex (CC0)